Thyroid Storm Clinical Presentation

  • Author: Madhusmita Misra, MD, MPH; Chief Editor: Stephen Kemp, MD, PhD   more...
 
Updated: Feb 27, 2012
 

History

Patients may have a known history of thyrotoxicosis. In the absence of previously diagnosed thyrotoxicosis, the history may include symptoms such as irritability, agitation, emotional lability, a voracious appetite with poor weight gain, excessive sweating and heat intolerance, and poor school performance caused by decreased attention span. Burch and Wartofsky have published precise criteria and a scoring system for the diagnosis of thyroid storm based on clinical features.[2]

  • General symptoms
    • Fever
    • Profuse sweating
    • Poor feeding and weight loss
    • Respiratory distress
    • Fatigue (more common in older adolescents)
  • GI symptoms
    • Nausea and vomiting
    • Diarrhea
    • Abdominal pain
    • Jaundice[3]
  • Neurologic symptoms
    • Anxiety (more common in older adolescents)
    • Altered behavior
    • Seizures, coma
Next

Physical

Physical findings include the following:

  • Fever
    • Temperature consistently exceeds 38.5°C.
    • Patients may progress to hyperpyrexia.
    • Temperature frequently exceeds 41°C.
  • Excessive sweating
  • Cardiovascular signs
    • Hypertension with wide pulse pressure
    • Hypotension in later stages with shock
    • Tachycardia disproportionate to fever
    • Signs of high-output heart failure
    • Cardiac arrhythmia (Supraventricular arrhythmias are more common, [eg, atrial flutter and fibrillation], but ventricular tachycardia may also occur.)
  • Neurologic signs
    • Agitation and confusion
    • Hyperreflexia and transient pyramidal signs
    • Tremors, seizures
    • Coma
  • Signs of thyrotoxicosis
    • Orbital signs
    • Goiter
Previous
Next

Causes

The causes of thyroid storm are as follows:

  • Thyroid storm is precipitated by the following factors in individuals with thyrotoxicosis:
    • Sepsis
    • Surgery
    • Anesthesia induction[4]
    • Radioactive iodine (RAI) therapy[5]
    • Drugs (anticholinergic and adrenergic drugs such as pseudoephedrine; salicylates; nonsteroidal anti-inflammatory drugs [NSAIDs]; chemotherapy[6] )
    • Excessive thyroid hormone (TH) ingestion
    • Withdrawal of or noncompliance with antithyroid medications
    • Diabetic ketoacidosis
    • Direct trauma to the thyroid gland
    • Vigorous palpation of an enlarged thyroid
    • Toxemia of pregnancy and labor in older adolescents; molar pregnancy
  • Thyroid storm can occur in children with thyrotoxicosis due to any cause but is most commonly associated with Graves disease. Other reported causes of thyrotoxicosis associated with thyroid storm include the following:
    • Transplacental passage of maternal thyroid-stimulating immunoglobulins in neonates
    • McCune-Albright syndrome with autonomous thyroid function[7]
    • Hyperfunctioning thyroid nodule
    • Hyperfunctioning multinodular goiter
    • Thyroid-stimulating hormone (TSH)–secreting tumor
  • Graves disease may also occur in children with Down syndrome or Turner syndrome and in association with other autoimmune conditions, including the following:
  • The pathophysiologic mechanisms of Graves disease are shown in the image below.Pathophysiologic mechanisms of Graves disease relaPathophysiologic mechanisms of Graves disease relating thyroid-stimulating immunoglobulins to hyperthyroidism and ophthalmopathy. T4 is levothyroxine. T3 is triiodothyronine.
  • Although the exact pathogenesis of thyroid storm is not fully understood, the following theories have been proposed:
    • Patients with thyroid storm reportedly have relatively higher levels of free THs than patients with uncomplicated thyrotoxicosis, although total TH levels may not be increased.
    • Adrenergic receptor activation is another hypothesis. Sympathetic nerves innervate the thyroid gland, and catecholamines stimulate TH synthesis. In turn, increased THs increase the density of beta-adrenergic receptors, thereby enhancing the effect of catecholamines. The dramatic response of thyroid storm to beta-blockers and the precipitation of thyroid storm after accidental ingestion of adrenergic drugs such as pseudoephedrine support this theory. This theory also explains normal or low plasma levels and urinary excretion rates of catecholamines. However, it does not explain why beta-blockers fail to decrease TH levels in thyrotoxicosis.
    • Another theory suggests a rapid rise of hormone levels as the pathogenic source. A drop in binding protein levels, which may occur postoperatively, might cause a sudden rise in free hormone levels. In addition, hormone levels may rise rapidly when the gland is manipulated during surgery, during vigorous palpation during examination, or from damaged follicles following RAI therapy.
    • Other proposed theories include alterations in tissue tolerance to THs, the presence of a unique catecholaminelike substance in thyrotoxicosis, and a direct sympathomimetic effect of TH as a result of its structural similarity to catecholamines.
Previous
 
 
Contributor Information and Disclosures
Author

Madhusmita Misra, MD, MPH  Associate Professor in Pediatrics, Harvard Medical School; Consulting Staff, Fellowship Program Director, Department of Pediatric Endocrinology, Massachusetts General Hospital

Madhusmita Misra, MD, MPH is a member of the following medical societies: Endocrine Society and Pediatric Endocrine Society

Disclosure: Genentech Grant/research funds Other

Coauthor(s)

Abhay Singhal, MD  Assistant Professor of Clinical Pediatrics, Department of Pediatrics, Division of Neonatology, Indiana University School of Medicine

Abhay Singhal, MD is a member of the following medical societies: American Academy of Pediatrics

Disclosure: Nothing to disclose.

Deborah E Campbell, MD  Professor of Clinical Pediatrics, Albert Einstein College of Medicine; Director, Department of Pediatrics, Division of Neonatology, Weiler Hospital Division of Montefiore Medical Center

Deborah E Campbell, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, National Perinatal Association, and New York Academy of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Phyllis W Speiser, MD  Chief, Division of Pediatric Endocrinology, Steven and Alexandra Cohen Children's Medical Center of New York; Professor of Pediatrics, Hofstra-North Shore LIJ School of Medicine at Hofstra University

Phyllis W Speiser, MD is a member of the following medical societies: American Association of Clinical Endocrinologists, Endocrine Society, Pediatric Endocrine Society, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Lynne Lipton Levitsky, MD  Chief, Pediatric Endocrine Unit, Massachusetts General Hospital; Associate Professor of Pediatrics, Harvard Medical School

Lynne Lipton Levitsky, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American Diabetes Association, American Pediatric Society, Endocrine Society, Pediatric Endocrine Society, and Society for Pediatric Research

Disclosure: Pfizer Grant/research funds P.I.; Tercica Grant/research funds Other; Eli Lily Grant/research funds PI; NovoNordisk Grant/research funds PI; NovoNordisk Consulting fee Consulting; Onyx Heart Valve Consulting fee Consulting

Merrily P M Poth, MD  Professor, Department of Pediatrics and Neuroscience, Uniformed Services University of the Health Sciences

Merrily P M Poth, MD is a member of the following medical societies: American Academy of Pediatrics, Endocrine Society, and Pediatric Endocrine Society

Disclosure: Nothing to disclose.

Chief Editor

Stephen Kemp, MD, PhD  Professor, Department of Pediatrics, Section of Pediatric Endocrinology, University of Arkansas for Medical Sciences College of Medicine, Arkansas Children's Hospital

Stephen Kemp, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association of Clinical Endocrinologists, American Pediatric Society, Endocrine Society, Phi Beta Kappa, Southern Medical Association, and Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

References
  1. Aiello DP, DuPlessis AJ, Pattishall EG 3d, Kulin HE. Thyroid storm. Presenting with coma and seizures. In a 3-year-old girl. Clin Pediatr (Phila). - DuPlessis AJ;28(12):571-4. [Medline].

  2. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. Jun 1993;22(2):263-77. [Medline].

  3. Hasan MK, Tierney WM, Baker MZ. Severe cholestatic jaundice in hyperthyroidism after treatment with 131-iodine. Am J Med Sci. Dec 2004;328(6):348-50. [Medline].

  4. Hirvonen EA, Niskanen LK, Niskanen MM. Thyroid storm prior to induction of anaesthesia. Anaesthesia. Oct 2004;59(10):1020-2. [Medline].

  5. Kadmon PM, Noto RB, Boney CM, et al. Thyroid storm in a child following radioactive iodine (RAI) therapy: a consequence of RAI versus withdrawal of antithyroid medication. J Clin Endocrinol Metab. May 2001;86(5):1865-7. [Medline]. [Full Text].

  6. Al-Anazi KA, Inam S, Jeha MT, Judzewitch R. Thyrotoxic crisis induced by cytotoxic chemotherapy. Support Care Cancer. Mar 2005;13(3):196-8. [Medline].

  7. Lawless ST, Reeves G, Bowen JR. The development of thyroid storm in a child with McCune-Albright syndrome after orthopedic surgery. Am J Dis Child. Sep 1992;146(9):1099-102. [Medline].

  8. US Food and Drug Administration. FDA MedWatch Safety Alerts for Human Medical Products. Propylthiouracil (PTU). Available at http://bit.ly/s0sNi. Accessed June 3, 2009.

  9. Petry J, Van Schil PE, Abrams P, Jorens PG. Plasmapheresis as effective treatment for thyrotoxic storm after sleeve pneumonectomy. Ann Thorac Surg. May 2004;77(5):1839-41. [Medline].

  10. [Best Evidence] [Guideline] Rivkees SA, Mattison DR. Ending propylthiouracil-induced liver failure in children. N Engl J Med. 2009;360(15):1574-5. [Medline]. [Full Text].

  11. Knighton JD, Crosse MM. Anesthetic management of childhood thyrotoxicosis and the use of esmolol. Anaesthesia. 1997;52(1):67-70. [Medline].

  12. Misra M, Levitsky LL, Lee MM. Transient hyperthyroidism in an adolescent with hydatidiform mole. J Pediatr. Mar 2002;140(3):362-6. [Medline].

  13. Morrison MP, Schroeder A. Intraoperative identification and management of thyroid storm in children. Otolaryngol Head Neck Surg. Jan 2007;136(1):132-3. [Medline].

  14. Ngo AS, Jung Tan DC. Thyrotoxic heart disease. Resuscitation. Jun 26 2006;[Medline].

  15. Rogers MC, Nichols DG. Thyroid storm. In: Textbook of Pediatric Intensive Care. 3rd ed. Baltimore, MD: Williams & Williams; 1996:1291-95.

  16. Sebe A, Satar S, Sari A. Thyroid storm induced by aspirin intoxication and the effect of hemodialysis: a case report. Adv Ther. May-Jun 2004;21(3):173-7. [Medline].

  17. Tietgens ST, Leinung MC. Thyroid Storm. Medical Clinics of North America. 1995;79(1):169-84. [Medline].

  18. Ureta-Raroque SS, Abramo TJ. Adolescent female patient with shock unresponsive to usual resuscitative therapy. Pediatr Emerg Care. Aug 1997;13(4):274-6. [Medline].

  19. Wartofsky L. Thyroid storm. In: Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. 6th ed. 1991:871-79.

  20. Wilson BE, Hobbs WN. Case report: pseudoephedrine-associated thyroid storm: thyroid hormone- catecholamine interactions. Am J Med Sci. Nov 1993;306(5):317-9. [Medline].

  21. Yoon SJ, Kim DM, Kim JU, et al. A case of thyroid storm due to thyrotoxicosis factitia. Yonsei Med J. Apr 30 2003;44(2):351-4. [Medline].

Previous
Next
 
Pathophysiologic mechanisms of Graves disease relating thyroid-stimulating immunoglobulins to hyperthyroidism and ophthalmopathy. T4 is levothyroxine. T3 is triiodothyronine.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.